When people think about global health, they tend to think about far-flung locales and communities of people different from their own. But the biggest challenges to global health like pandemic preparedness, antimicrobial resistance, biological warfare, and systemic environmental degradation are omnipresent, and you don’t feel their effects in our daily lives.
And while these challenges are difficult to address, let alone solve, that doesn’t mean they shouldn’t be addressed. To us, tackling these seemingly insurmountable problems is the only thing there is.
At Biomeme, we embrace the enormity of these challenges and commit to tackling them head on.
Here’s how:
- Pandemic Preparedness: Our switch and decisive response during the COVID-19 pandemic underscores our technology’s agility and our company’s dedication to crisis management. By quickly developing and deploying accurate and rapid COVID-19 diagnostic tools, such as our FDA EUA* SARS-CoV-2 test on our Franklin® platform, in collaboration with groups like One Health Labs, we empowered healthcare providers big and small to make informed decisions and curtail the virus’s spread.
- The Antimicrobial and Antibiotic Resistance Crisis: The overuse of antibiotics and other antimicrobials has led to the rise of drug-resistant organisms, posing a grave threat to medical treatment efficacy. Biomeme’s fast and precise diagnostic solutions provide physicians with the tools to make accurate diagnoses and prescribe antibiotics more judiciously.
- Advancing One Health: The concept of One Health is a recognition that the health of humans, animals, and the environment are interconnected; when one suffers, all suffer. Everything we do in diagnosing and fighting against infectious diseases is with One Health in mind, recognizing that better, faster and more accurate diagnoses yield better outcomes across ecosystems.
We always knew there were broad challenges that needed solving, but only in recent years have we shifted our company and brand purpose to focus on them. We’ve changed in several ways since our founding a decade ago, and those changes are part of the reason we have relaunched our brand.
A Lot Has Changed in a Decade. We Have, Too.
Our tests, technologies, and platforms offer answers on a molecular level faster than ever. These are answers that weren’t previously available and are essential to improving global health.
Biomeme’s First Host Response Test That Differentiates Bacterial and Viral Infections (HR-B/V)
Our breakthrough HR-B/V test is a testament to our commitment to innovation. This unique test hopes to provide diagnosticians with an accurate, molecular-level understanding of whether an illness is viral, bacterial, or fungal. This information guides precise treatment plans, reducing the overuse of antibiotics and improving patient outcomes.
Real-Time, On-Site Testing with the Biomeme Franklin® ISP
Our Franklin® ISP is a game-changer in point-of-need diagnostics. Offering lab-quality results in real-time, this technology empowers healthcare professionals to make critical decisions quickly, enhancing care and streamlining healthcare workflows.
The Significance of Point-of-Need Diagnostics
Timely and accurate diagnoses are essential for reducing infection rates and strengthening our collective defense against health crises. Our point-of-need diagnostic solutions bridge the gap between detection and action, ensuring that effective measures are taken promptly.
Forging the Future: Where Innovation Thrives
Let's take a moment to reflect on the road we've traveled, facing down global health challenges head-on. Whether it's been fortifying our defenses against pandemics or tackling the ominous specter of antimicrobial resistance, one thing remains crystal clear: Biomeme has consistently stood as a beacon of scientific innovation. But let's not stop at simply patting ourselves on the back. We're standing at a crossroads, and the path ahead holds even greater promise.
Our fusion of technology, determination, and efficiency propels us beyond conventional limits. This journey isn't just about host response for us—it's about transcending boundaries, fostering unity through One Health, and redefining what's possible in the pursuit of a healthier world.
Our achievements are milestones, not destinations. Host response capabilities are merely the tip of the iceberg. As we face the future, we embark on a path where breakthroughs reshape health norms, where challenges are springboards, and where our history of innovation and resilience continues to write new chapters. The canvas of scientific exploration stretches before us, awaiting the strokes of progress we're poised to make.
Why Rebrand?
Sometimes companies rebrand when they want to shake things up. For others, it’s about updating an identity that reflects who you’ve already become. That’s why we did it.
We’re excited for the future, and we’re looking for partners who are, too.
Want to learn more about partnering with Biomeme? Let’s chat.
*The Biomeme SARS-CoV-2 Assay has not been FDA cleared or approved, but has been authorized by FDA under an EUA for use by authorized laboratories only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses or pathogens. The emergency use of this product is only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the declaration is terminated or authorization is revoked sooner.
Products currently under development and not approved/cleared by the FDA.
